Year-two follow-up results of an observational study conducted in Crohn's disease and ulcerative colitis patients treated with infliximab biosimilar CT-P13 in a real-life setting

被引：0
|
作者：
Laharie, D. [1 ]
Pierron, G. [2 ]
Brault, Y. [3 ]
Bouhnik, Y. [4 ]
Nancey, S. [5 ,6 ]
机构：
[1] Univ Hosp Ctr Bordeaux, Dept Gastroenterol, Bordeaux, France
[2] Pfizer, Inflammat & Immunol, Paris, France
[3] Pfizer, Stat, Paris, France
[4] Paris IBD Ctr, Grp Hosp Prive Ambroise Pare Hartmann, Neuilly Sur Seine, France
[5] Lyon South Hosp Pierre Benite, Lyon, France
[6] INSERM, U1111 CIRI, Dept Gastroenterol, Lyon, France
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P529
引用
收藏
页码：658 / 659
页数：2
相关论文
共 50 条
  • [31] PHASE III RANDOMIZED CONTROLLED TRIAL TO COMPARE BIOSIMILAR INFLIXIMAB (CT-P13) WITH INNOVATOR INFLIXIMAB IN PATIENTS WITH ACTIVE CROHN'S DISEASE: 1-YEAR MAINTENANCE AND SWITCHING RESULTS
    Ye, Byong Duk
    Kim, Young Ho
    Pesegova, Marina
    Alexeeva, Olga
    Osipenko, Marina
    Lahat, Adi
    Dorofeyev, Andriy
    Salamon, Agnes
    Fishman, Sigal
    Levchenko, Olena
    Cheon, Jae Hee
    Scribano, Maria Lia
    Mateescu, Radu-Bogdan
    Lee, Kang-Moon
    Eun, Chang Soo
    Lee, Sang Joon
    Lee, Sung Young
    Schreiber, Stefan
    GASTROENTEROLOGY, 2018, 154 (06) : S167 - S168
  • [32] Real-life drug persistence in patients with rheumatic diseases treated with CT-P13: a prospective observational cohort study (PERSIST)
    Taylor, Peter C.
    Christensen, Robin
    Moosavi, Shahrzad
    Selema, Pamela
    Guilatco, Ruffy
    Fowler, Heather
    Mueller, Markus
    Liau, Katherine F.
    Haraoui, Boulos
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2021, 5 (02)
  • [33] Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months
    F. Argüelles-Arias
    M. F. Guerra Veloz
    R. Perea Amarillo
    A. Vilches-Arenas
    L. Castro Laria
    B. Maldonado Pérez
    D. Chaaro
    A. Benítez Roldán
    V. Merino
    G. Ramírez
    A. Caunedo Álvarez
    M. Romero Gómez
    Digestive Diseases and Sciences, 2017, 62 : 2203 - 2203
  • [34] Biosimilar infliximab in real-life Crohn's disease's anti-TNFalfa naive patients: a comparative observational cohort study (SIMRECRO study)
    Carvalho Lourenco, L.
    Anapaz, V.
    Oliveira, A. M.
    Branco, J.
    Cardoso, M.
    Graca Rodrigues, C.
    Santos, L.
    Horta, D.
    Martins, A.
    Reis, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S259 - S259
  • [35] ECCO 2018: British Observational Study shows Comparability of Iinfliximab Biosimilar CT-P13 with Reference Infliximab and Adalimumab in Patient with Crohn's Disease (CD)
    不详
    VISCERAL MEDICINE, 2018, 34 (02) : 158 - 158
  • [36] Subcutaneous infliximab (CT-P13 SC) for ulcerative colitis: 2-year extension results of the LIBERTY-UC study
    Sands, B. E.
    Hanauer, S. B.
    Colombel, J. F.
    Sandborn, W. J.
    Schreiber, S.
    Danese, S.
    Klopocka, M.
    Kulynych, R.
    Kierkus, J.
    Soltysiak, A.
    Smolinski, P.
    Gonciarz, M.
    Sreckovic, S.
    Valuyskikh, E.
    Horynski, M.
    Gasbarrini, A.
    Lee, S. J.
    Kim, S.
    Bae, Y.
    Lee, S.
    Lee, S. G.
    Lee, J. H.
    Kim, J. M.
    Lee, J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1727 - I1728
  • [37] REAL-WORLD SAFETY DATA FROM PATIENTS WITH RHEUMATIC DISEASES TREATED WITH CT-P13, AN INFLIXIMAB BIOSIMILAR: AN INTERIM ANALYSIS FROM AN OBSERVATIONAL STUDY
    Taylor, Peter C.
    Christensen, Robin
    Moosavi, Shahrzad
    Selema, Pamela
    Guilatco, Ruffy
    Fowler, Heather
    Bombardier, Claire
    Haraoui, Boulos
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 729 - 729
  • [38] SUBCUTANEOUS INFLIXIMAB (CT-P13 SC) FOR ULCERATIVE COLITIS: 2YEAR EXTENSION RESULTS OF THE LIBERTY-UC STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Hanauer, Stephen B.
    Colombel, Jean Frederic
    Schreiber, Stefan
    Danese, Silvio
    Klopocka, Maria
    Kulynych, Roman
    Kierkus, Jaroslaw
    Soltysiak, Artur
    Smolinski, Patryk
    Gonciarz, Maciej
    Sreckovic, Slobodan
    Valuyskikh, Ekaterina
    Horynski, Marek
    Gasbarrini, Antonio
    Lee, Sang Joon
    Kim, Sung Hyun
    Bae, Yunju
    Lee, Sunhee
    Lee, Seul Gi
    Lee, Joon Ho
    Kim, Jong Min
    Lee, Ji Min
    GASTROENTEROLOGY, 2024, 166 (05) : S810 - S810
  • [39] Infliximab-Biosimilar CT-P13 Phase-III-Study confirms Non-Inferiority for Reference in Patients with Crohn's Disease
    不详
    VISCERAL MEDICINE, 2019, 35 (03) : 198 - 198
  • [40] Long-Term Follow-Up of Patients Treated with Infliximab for Ulcerative Colitis: Predictive Factors of Response—An Observational Study
    Orlando García-Bosch
    Montserrat Aceituno
    Ingrid Ordás
    Josefina Etchevers
    Miquel Sans
    Faust Feu
    Julián Panés
    Elena Ricart
    Digestive Diseases and Sciences, 2016, 61 : 2051 - 2059
12345